Global Pharmaceuticals & Biotech Most Popular Stocks

Bayer

Market Cap: €26.8b

Operates as a life science company worldwide.

IQVIA Holdings

Market Cap: US$30.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Insmed

Market Cap: US$29.8b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Otsuka Holdings

Market Cap: JP¥4.2t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Celltrion

Market Cap: ₩39.2t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Hansoh Pharmaceutical Group

Market Cap: HK$215.3b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Mettler-Toledo International

Market Cap: US$25.6b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Sandoz Group

Market Cap: CHF 20.0b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

BioNTech

Market Cap: US$24.0b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Natera

Market Cap: US$22.5b

A diagnostics company, provides molecular testing services worldwide.

Teva Pharmaceutical Industries

Market Cap: US$22.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Sichuan Biokin PharmaceuticalLtd

Market Cap: CN¥151.8b

Engages in the research and development, production, and supply of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally.

Innovent Biologics

Market Cap: HK$162.8b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$162.6b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Royalty Pharma

Market Cap: US$20.9b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Biogen

Market Cap: US$20.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Astellas Pharma

Market Cap: JP¥3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

United Therapeutics

Market Cap: US$19.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Sartorius Stedim Biotech

Market Cap: €17.0b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

West Pharmaceutical Services

Market Cap: US$18.7b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Sino Biopharmaceutical

Market Cap: HK$143.3b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Divi's Laboratories

Market Cap: ₹1.6t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Genmab

Market Cap: DKK 114.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Waters

Market Cap: US$17.4b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

ALTEOGEN

Market Cap: ₩24.3t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥119.4b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

Incyte

Market Cap: US$16.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Akeso

Market Cap: HK$125.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$118.5b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Summit Therapeutics

Market Cap: US$15.2b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Shionogi

Market Cap: JP¥2.2t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

Neurocrine Biosciences

Market Cap: US$14.5b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Illumina

Market Cap: US$14.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Yunnan Baiyao GroupLtd

Market Cap: CN¥102.2b

Engages in the pharmaceutical business in China.

Medpace Holdings

Market Cap: US$14.0b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Tempus AI

Market Cap: US$13.8b

Operates as a healthcare technology company.